Sjogren's Syndrome Trial, Recruiting NCT04806620 Sponsor: Brain Inflammation Collaborative Condition: Sjogren's Syndrome
Back to Sjogrens Syndrome

Sjogren's Syndrome Trial, Recruiting

NCT04806620
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been told by a doctor — or believe yourself — that you have a condition linked to an infection, such as Long COVID, chronic Lyme disease, ME/CFS, or PANS/PANDAS
  • You have been told by a doctor — or believe yourself — that you have a nerve, immune system, or autonomic nervous system condition, such as migraines, POTS, multiple sclerosis, or autism spectrum disorder
  • You have been told by a doctor — or believe yourself — that you have an autoimmune disease, such as Lupus, Sjögren's Disease, rheumatoid arthritis, or a similar condition
  • You have been told by a doctor — or believe yourself — that you have an inflammatory gut condition, such as Crohn's Disease, Celiac Disease, or ulcerative colitis
  • You have been told by a doctor — or believe yourself — that you have a mood or behavioral condition, such as anxiety, depression, bipolar disorder, PTSD, OCD, or a related condition
  • You are a healthy person with no known illness, including family members or household members of people with these conditions
  • You have reliable internet access and own or can use a phone, tablet, or computer
  • You currently live in the United States
  • You are able to participate in English
  • You are willing to share your symptom and health information through the trial's app or online platform

Who may not be able to join:

  • There are no specific exclusion criteria listed in the official trial description (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Megan L Fitzgerald, PhD, Brain Inflammation Collaborative

Phone: 1-833-286-4433

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Brain Inflammation Collaborative
Registry
ClinicalTrials.gov
Start date
5 July 2023
Est. completion
30 June 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Phenotypic data collection; Subtyping; Passive data collection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov